Marijuana Rated Significantly More Effective in Treating Fibromyalgia Symptoms than FDA-Approved Drugs
Apr 21, 2014 - 9:11:22 AM
The three drugs approved for the treatment of fibromyalgia are Cymbalta (Duloxetine); Lyrica (Pregabalin); and Savella (Milnacipran).
How Cymbalta Performs for Fibromyalgia Sufferers (N=960)
-- 60% say Cymbalta does not work at all
-- 32% say Cymbalta helps a little
-- 8% say Cymbalta was very effective
How Lyrica Performs for Fibromyalgia Sufferers (N=860)
-- 61% say Lyrica does not work at all
-- 29% say Lyrica helps a little
-- 10% say Lyrica was very effective
How Savella Performs for Fibromyalgia Sufferers (N=387)
-- 68% say it does not work at all
-- 22% say it helps a little
-- 10% say it was very effective
How Marijuana Performs for Fibromyalgia Sufferers (N=379)
-- 5% say it does not work at all
-- 33% marijuana helps a little
-- 62% say marijuana was very effective
Comments from survey respondents regarding the use of marijuana to treat Fibromyalgia:
-- "I've found nothing that has worked for me, apart from marijuana."
-- "Nothing but medical marijuana has made the greatest dent in the pain
and mental problems."
-- "Marijuana does help a LOT, it numbs the pain. But, it doesn't last long
and it makes your brain foggy."
Ninety-six percent (96%) of survey respondents were females. About half (49%) were diagnosed between the ages of 18 and 34, while 38% were diagnosed between the ages of 35 to 49. Only 12% were diagnosed at the age of 50 or older.
Forty-four percent (44%) lived with Fibromyalgia for more than five years before receiving a diagnosis. Only 11% were diagnosed within one year of experiencing symptoms.
Four out of ten (43%) of fibromyalgia sufferers feel their physician is not knowledgeable about the disorder. Over a third (35%) feel their physician does not take their fibromyalgia seriously. And 45% feel their family and friends do not take their fibromyalgia seriously.
About The National Pain Foundation
The National Pain Foundation is a 501(c)(3), not-for-profit organization that is addressing the critical public health challenges attributed to pain on a global basis.
Web Site: http://www.
For advertising/ promotion on HealthNewsDigest.com, call Mike McCurdy at: 877-634-9180. We have over 7,000 journalists as subscribers and may use our content